PeptideDB

MI-2 (MALT1 inhibitor) 1047953-91-2

MI-2 (MALT1 inhibitor) 1047953-91-2

CAS No.: 1047953-91-2

MI-2 (also known as MALT1 inhibitor) is a potent and irreversible MALT1 inhibitor with IC50 of 5.84 μM, and binds direc
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

MI-2 (also known as MALT1 inhibitor) is a potent and irreversible MALT1 inhibitor with IC50 of 5.84 μM, and binds directly to MALT1, irreversibly suppresses protease function. MI-2 inhibits MALT1 functions in ABC-DLBCL cell lines with excellent cell penetration. MI-2 binds directly to MALT1 and irreversibly suppresses protease function. Decreases NF-κB activity induced by MALT1. MI-2 produces selective growth inhibition for MALT1-dependent cell lines with GI50 of 0.2, 0.5, 0.4, and 0.4 μM in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells, whereas the ABC-DLBCL MALT1-independent cell lines, U2932 and HLY-1, and the two GCB-DLBCL cell lines were resistant.



Physicochemical Properties


Molecular Formula C19H17CL3N4O3
Molecular Weight 455.72
Exact Mass 454.037
CAS # 1047953-91-2
Related CAS #
1047953-91-2
PubChem CID 45942672
Appearance White to off-white solid powder
Density 1.44±0.1 g/cm3
LogP 4.516
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 5
Rotatable Bond Count 8
Heavy Atom Count 29
Complexity 525
Defined Atom Stereocenter Count 0
InChi Key TWJGQZBSEMDPQP-UHFFFAOYSA-N
InChi Code

InChI=1S/C19H17Cl3N4O3/c1-28-8-9-29-19-24-18(12-2-7-15(21)16(22)10-12)26(25-19)14-5-3-13(4-6-14)23-17(27)11-20/h2-7,10H,8-9,11H2,1H3,(H,23,27)
Chemical Name

2-chloro-N-[4-[5-(3,4-dichlorophenyl)-3-(2-methoxyethoxy)-1,2,4-triazol-1-yl]phenyl]acetamide
Synonyms

MI-2; MI 2; MI2; MALT1 inhibitor
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro MALT1-dependent DLBCL cell lines are selectively suppressed by the MALT1 inhibitor MI-2 (1-1000 nM; 48 hours); the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 μM, respectively[1]. MALT1-mediated cleavage is reduced in a dose-dependent manner by the MALT1 inhibitor MI-2 (62-1000 nM; 24 hours)[1]. MALT1 blocker
ln Vivo The growth of TMD8 and HBL-1 ABC-DLBCL xenografts is significantly suppressed by the MALT1 inhibitor MI-2 (25 mg/kg; ip; daily for 14 days)[1].
Cell Assay Cell Proliferation Assay[1]
Cell Types: HBL -1, TMD8, OCI-Ly3, OCI-Ly10 cells
Tested Concentrations: 1, 10, 100, 1000 nM
Incubation Duration: 48 hrs (hours)
Experimental Results: The GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells was 0.2, 0.5, 0.4, and 0.4 µM, respectively.

Western Blot Analysis[1]
Cell Types: HBL-1 cells
Tested Concentrations: 62, 125, 250, 500, 1000 nM
Incubation Duration: 24 hrs (hours)
Experimental Results: Inhibits MALT1 cleavage of CYLD in HBL -1 cells.
Animal Protocol Animal/Disease Models: Eightweeks old male SCID NOD ( bearing HBL-1 and TMD8 cells)[1]
Doses: 25 mg/kg
Route of Administration: intraperitoneal (ip)injection; daily for 14 days
Experimental Results: Profoundly suppressed the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts versus vehicle.
References

[1]. MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo. Cancer Cell. 2012 Dec 11;22(6):812-24.

Additional Infomation MALT1 Inhibitor is any agent that inhibits mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1).

Solubility Data


Solubility (In Vitro)
DMSO:91 mg/mL (199.7 mM)
Water:<1 mg/mL
Ethanol:21 mg/mL (46.1 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.5 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.5 mg/mL (5.49 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

Solubility in Formulation 3: 2% DMSO +30%PEG 300: 5 mg/mL

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1943 mL 10.9716 mL 21.9433 mL
5 mM 0.4389 mL 2.1943 mL 4.3887 mL
10 mM 0.2194 mL 1.0972 mL 2.1943 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.